Brenner Tumor - 50 Studies Found Completed : Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer : Brenner Tumor Ovarian Clear Cell Cystadenocarcinoma : 1999-11-01 : Drug: paclitaxel Given IV Completed : Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin : Brenner Tumor Fallopian Tube Cancer Drug: belinostat Given IV Completed : Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy : Brenner Tumor Fallopian Tube Cancer Biological: sargramostim Given Completed : Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma : Brenner Tumor Fallopian Tube Cancer Drug: paclitaxel Given IV Recruiting : Metformin Hydrochloride and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer : Brenner Tumor Malignant Ascites Drug: paclitaxel Given IV Completed : Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) : Brenner Tumor Fallopian Tube Cancer Drug: carboplatin Given intrap Completed : Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer : Brenner Tumor Fallopian Tube Cancer Procedure: adjuvant therapy Drug: paclitax Recruiting : Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer : Ovarian Brenner Tumor Ovarian Carcinosarcoma Drug: Gemcitabine Hydrochloride Completed : TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer : Malignant Ovarian Mixed Epithelial Tumor Ovarian Brenner Tumor< : 2011-02-10 : Drug: TLR8 Agonist VTX-2337 Gi Suspended : Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer : Nausea and Vomiting Ovarian Brenner Tumor Procedure: Adjuvant Therapy An Next >>>